《Table 1 Demographic and patient-referred data》

《Table 1 Demographic and patient-referred data》   提示:宽带有限、当前游客访问压缩模式
本系列图表出处文件名:随高清版一同展现
《Safety of intrathecal injection of Wharton's jellyderived mesenchymal stem cells in amyotrophic lateral sclerosis therapy》


  1. 获取 高清版本忘记账户?点击这里登录
  1. 下载图表忘记账户?点击这里登录
WJ-MSC:Wharton’s jelly-derived mesenchymal stem cells.

Forty-three patients,consisting of 16 females and 27males,aged 57.3 years,were included in the final analysis.The mean weight of patients was 75.35 kg at the beginning of the therapy.The mean dose of WJ-MSC in one intrathecal injection was 0.42×106 cells/kg(Table 1).All patients were treated with riluzole 100 mg in 2 doses per day.